Levosimendan

Levosimendan
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T2530-25mg 25 mg

7 - 10 business days*

31.00€
TGM-T2530-50mg 50 mg

7 - 10 business days*

45.00€
TGM-T2530-100mg 100 mg

7 - 10 business days*

60.00€
TGM-T2530-200mg 200 mg

7 - 10 business days*

102.00€
TGM-T2530-500mg 500 mg

7 - 10 business days*

236.00€
 
Description: Levosimendan (OR1259) is a calcium sensitizer used in the management of acutely... more
Product information "Levosimendan"
Description: Levosimendan (OR1259) is a calcium sensitizer used in the management of acutely decompensated congestive heart failure. It increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its effect by increasing calcium sensitivity of myocytes by binding to cardiac troponin C in a calcium-dependent manner. Target: PDE, Carbonic Anhydrase, Potassium Channel, Autophagy. Smiles: C[C@H]1C(C2=CC=C(NN=C(C#N)C#N)C=C2)=NNC(=O)C1. References: Haikala H, J Mol Cell Cardiol, 1995, 27(9), 1859-1866.
Keywords: OR1855, OR1259
Supplier: TargetMol
Supplier-Nr: T2530

Properties

Application: Cardiotonic, Phosphodiesterase inhibitor
MW: 280.28 D
Formula: C14H12N6O

Database Information

CAS : 141505-33-1| Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H302, H312, H332
P Phrases: P261, P264, P270, P271, P280, P312, P321, P330, P301+P310, P302+P352, P304+P340, P361+P364, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Levosimendan"
Write a review
or to review a product.
Viewed